Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07160673

Tech-based Respite Care for Caregivers and Homebound Older Adults

Conditions: Caregiver Stress, Social Isolation in Older Adults, Cognitive Decline in Older Adults, Depression in Older Adults, Anxiety in Older Adults

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 180
Sponsor: Hong Kong University

Location: Sau Po Centre on Ageing, HKU Hong Kong 香港島

Summary

The goal of this study is to examine the effectiveness of VR-based respite in improving cognitive function, mental health, and quality of life in caregivers and homebound older adults compared to a control group using videos and a usual care group. Participants are randomly assigned to one of three groups: VR intervention, video control, or usual care. The VR group receives immersive VR sessions using the SilVR Adventures platform. The video group receives non-immersive video sessions with similar content. The usual care group receives no additional intervention. Assessments are conducted at baseline, immediate post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, loneliness, quality of life, and other outcomes. The intervention dosage will be 4 weeks (1 sessions/week; 30 min/session). Secondarily, the study explores differences in effectiveness between caregivers and homebound older adults, and potential moderators or mediators such as baseline health status, technological literacy, and social support.

Eligibility Criteria

Caregivers (CGs) Inclusion Criteria: * Aged 18 or above * Provide care to at least one homebound older adult (aged 60 or above) * Provide no less than 6 hours of caregiving per week * Able to communicate in either Cantonese, Mandarin or English * Willing to participate for the entire duration * Able to tolerate VR headset for at least 5 minutes (no severe motion sickness/epilepsy) Exclusion Criteria: * History of severe psychiatric disorders (e.g., schizophrenia, bipolar) * Severe cognitive impairment (MMSE \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07160673). StuddyBuddy aggregates publicly available trial information.